CNS Neurosci Ther, 2024 · DOI: 10.1111/cns.14806 · Published: May 18, 2024
This study investigates the antioxidant role of glucose-dependent insulinotropic polypeptide (GIP) on neurons and explores the possible mechanisms behind it. The research found that GIP reduces reactive oxygen species (ROS) levels and protects cells from apoptosis in both cultured neurons and injured spinal cords. It also facilitates wound healing and functional recovery after spinal cord injury. The study showed GIP increases glucose transporter 3 (GLUT3) expression via up-regulating the level of hypoxia-inducible factor 1α (HIF-1α) in an Akt-dependent manner, contributing to its antioxidant effect.
GIP and GIPR agonists could be potential therapeutic agents for spinal cord injury, combining neuronal protection and axon regeneration.
The study provides a mechanism insight into the protective effect of GIP on neurons under oxidative stress through the GIP-Akt-HIF-1α-GLUT3 signaling axis.
GIP and GIPR agonists' ability to cross the blood–brain barrier enhances their potential for therapeutic application in CNS injuries.